Localization of biotinylated monoclonal antibody in nude mice bearing subcutaneous and intraperitoneal human tumour xenografts
โ Scribed by S. Pervez; G. Paganelli; A. A. Epenetos; W. J. Mooi; D. J. Evans; T. Krausz
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 466 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
To demonstrate the precise distribution and binding of in vivo injected monoclonal antibodies on histological tumour sections, we have biotinylated our primary antibody AUA I. Biotinylated antibody was injected into nude mice bearing simultaneous subcutaneous and intraperitoneal xenografts of the human tumour LoVo. Twenty-four hours after injection, the animals were killed, tumours and control organs were removed. Antibody was demonstrated on frozen sections by incubating sections w i t h avidin biotin peroxidase complex. We compared the in vivo penetration and binding of this antibody on intraperitoneal and subcutaneous xenografts. The antibody penetration was mainly restricted t o a thin layer of tumour cells adjacent t o the vascularized stroma i n large solid subcutaneous and intraperitoneal tumours, whereas in very small intraperitoneal turnours, antibody penetration was complete. These findings were similar to our autoradiographic results. This study demonstrates that employing the biotinylated antibodies for in vivo localization studies provides superior resolution of antibody binding for morphological assessment compared t o autoradiography. Localization of a biotin label i s more precise and will permit ultra-structural studies.
๐ SIMILAR VOLUMES
Background. Many studies have demonstrated synergistic interaction between hyperthermia and radiation. This study was undertaken to determine whether hyperthermia could enhance the effect of radioimmunotherapy (RIT) in the treatment of human colon adenocarcinoma xenografts in nude mice. The experim
## Background: Some vasoactive drugs have been studied in the hope of altering the vascular permeability and/or blood of tumors to enhance monoclonal antibody (moab) uptake. the pretreatment of interleukin-2 (il-2), one of the vasoactive reagents, produced a generalized vascular permeability, but i
## BACKGROUND. The immunoglobulin G 1 (IgG 1 ) monoclonal